Oncolytic Adenovirus-Mediated Expression of CCL5 and IL12 Facilitates CA9-Targeting CAR-T Therapy Against Renal Cell Carcinoma

Author:

Fang Lin,Tian Weiping,Zhang Chen,Wang Xueyan,Li Wanjing,Zhang Qi,Zhang Yuxin,Zheng Junnian

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference33 articles.

1. These results suggested that the combination of Ad5-ZD55-CCL5-IL12 and CA9-CAR-T effectively suppressed the growth of CIAX-positive renal carcinoma cells in vitro;CA9-CAR-T group and the responded control group (Figure 3F)

2. Renal cell carcinoma pathology in 2021: 'new need for renal cancer immune profiling;B Sobottka;Curr Opin Urol,2021

3. Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies;Y Xiao;Int J Mol Sci,2019

4. Renal cell carcinoma in one year: Going inside the news of 2017 -A report of the main advances in RCC cancer research;C Mosillo;Cancer Treat Rev,2018

5. Combination of CTLA-4 and PD-1 blockers for treatment of cancer;A Rotte;J Exp Clin Cancer Res,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3